Clinical Ink

Winston-salem, United States Founded: 2006 • Age: 20 yrs Acquired By GI Partners
Paperless eSource and patient engagement solutions for clinical trials

About Clinical Ink

Clinical Ink is a Healthcare company based in Winston-salem (United States) founded in 2006, and was acquired by GI Partners in August 2020. Paperless eSource and patient engagement solutions for clinical trials. Clinical Ink has raised $13.15 million across 9 funding rounds from investors including SVB, GI Partners and RTI International. Clinical Ink has completed 1 acquisition, including Digital Artefacts. Its chief executive, as recorded, is Jonathan Goldman. Its website clinicalink.com draws about 32 thousand monthly visits. Clinical Ink offers products and services including eCOA, Direct Data Capture, and eConsent. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.

Company details

Clinical Ink was founded in 2006 and is headquartered in Winston-Salem, United States. eSource solutions are offered through the SureSource platform, which enables electronic capture of data and documents at clinical trial sites. The CentrosHealth platform supports patient engagement via configurable apps to maintain involvement and compliance. Services target pharmaceutical companies, medical device firms, academic institutions, and contract research organizations in the global clinical trials sector.

  • Headquarters Winston-salem, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website clinicalink.com
  • Social LinkedIn X YouTube
  • Acquired by GI Partners (Aug 2020)
  • Legal Name Clinical Ink
Key Metrics

Products & Services of Clinical Ink

Clinical Ink offers a comprehensive portfolio of products and services, including eCOA, Direct Data Capture, and eConsent.

eCOA
Electronic Clinical Outcome Assessments

Platform for capturing and managing clinical trial outcomes electronically.

Direct Data Capture
Data Collection Tools

Software to validate real-time data from trials and devices.

eConsent
Patient Engagement

System for simplifying electronic consent in clinical studies.

Apps and channels of Clinical Ink

Clinical Ink publishes 1 mobile app with over 1K+ downloads; its YouTube channel Clinical ink has 72 subscribers and 7 videos.

Clinical ink
Google Play Medical Everyone Free 1K+ downloads
Developer: Clinical Ink, Inc.
View on Google Play
Clinical ink
YouTube 72 subscribers 7 videos Science & Technology
Open channel

Videos from Clinical Ink

The most watched videos on Clinical Ink's YouTube channel, Clinical ink (72 subscribers). Click a video to play it here.

Power Patient Outcomes with Clinical ink
1.1K views
Power Digital Assessments with Advanced Analytics by Clinical ink
842 views
Deploy a Smarter eCOA with Clinical ink
496 views
Clinical ink Parkinson's Digital Assessments
359 views

More on Clinical ink.

Funding Insights of Clinical Ink

Clinical Ink has successfully raised a total of $13.15M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $13.15M
  • Total Rounds 9
  • Investors Count 7

All 9 funding rounds of Clinical Ink with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2026Series D––
May 2018Debt – Venture––
May 2018$5.31MSeries C––
–
Jun 2017Series C––
Mar 2015Series C––
Oct 2013$4.3MSeries B–FCA Venture Partners
–
Dec 2011$3.13MSeries A––
–
Jul 2010$400,000Seed––
–
Jun 2006Debt – Conventional––
Valuation history

9 investors in total: 9 institutional.

Investors in Clinical Ink

Clinical Ink has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, GI Partners and RTI International.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage tech-focused venture capital firm investing primarily in the US
diokoventures.comWinston-salem, United States
VC investments are handled by the McWhorter family office.
claytonassociates.comNashville, United States
Offline-focused VC firm investing primarily in the US
fcavp.comBrentwood, United States
Debt and equity investments are offered by the firm.
2006solarcapltd.comNew York, United States
Data infrastructure companies are targeted for private equity investments.
2001gipartners.comSan Francisco, United States
PE firm focused on life science and healthcare companies
novaquest.comRaleigh, United States
Banking services are provided to innovative companies, investors, and individuals.
1983svb.comSanta Clara, United States
Invests in biotech firms developing life-saving drugs and technologies.
mpmcapital.com
Research institute for improving the human condition by turning knowledge into practice
1958rti.orgUnited States
Premium access

Investor details for Clinical Ink

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Clinical Ink

108 people are tracked at Clinical Ink (24 in leadership, 4 in board & advisors, 80 in team).

NameRoleGroup
Jonathan Goldman
CEOLeadership
Andrew Kraus
CTOLeadership
Diane Verso Wealand
Director Of EngineeringLeadership
George Slavish
Vice President, Business Intelligence And Process OperationsLeadership
Bill Barrasso
VP of Project OperationsLeadership
Deepika Gosain
Vice President, Business DevelopmentLeadership
Scott Miltenberger
Chief Financial OfficerLeadership
Pinal Patel
Senior Director Of EngineeringLeadership
Samantha Clark
Senior Director, Vendor Management & ProcurementLeadership
Brian Olson
Vice President - Development ServicesLeadership
Kathryn Davidson, SHRM-SCP
Vice President, Human ResourcesLeadership
John Pappadakis
Chief Commercial Officer (cco)Leadership
Richard Strang
Senior Director Of Information TechnologyLeadership
Alisa Dube
Director, Program ManagementLeadership
Megan Petrylak
Chief Operating OfficerLeadership
Michael C. Olenick
Senior Vice President, Project ManagementLeadership
Alexis Rejeski
Vice President, Supply Chain And Support ServicesLeadership
Jeff Bock
Vice President, Data ManagementLeadership
Arkadiusz G.
Business Development Director EMEALeadership
Thomas Becton
Senior Program DirectorLeadership

88 more people are available in the full profile.

Premium access

Complete people profiles for Clinical Ink

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Clinical Ink

Clinical Ink has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Digital Artefacts.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of the clinical trial management platform
digitalartefacts.comIowa, United States1999Nov 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for Clinical Ink

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Clinical Ink

6 dated milestones of Clinical Ink across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Clinical Ink is founded.
  2. Funding First funding round.
  3. Exit Acquired by RTI International.
  4. Exit Acquired by GI Partners.
  5. Acquisition Acquires Digital Artefacts.
  6. Funding Latest funding round, Series D,.

Competitors of Clinical Ink

Clinical Ink has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
trinetx.com2013Cambridge, United States$53M95
Clinical trial management software is provided for researchers and professionals.
Premium access

Detailed competitors of Clinical Ink

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Clinical Ink

The website of Clinical Ink (clinicalink.com) receives about 31.7K visits a month and ranks #500,834 among all websites worldwide, #495 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    31.7K

    ▲ 9.4% vs previous month

  • Unique visitors
    10.6K

    per month

  • Global rank
    #500,834

    among all websites

  • Category rank
    #495

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Clinical Ink. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
signanthealth.com
100%
94.5K#272,978View details
wcgclinical.com
97%
97.9K#286,468View details
worldwide.com
93%
89.1K#546,596View details
clinicalleader.com
88%
680.7K#948,222View details
ppd.com
82%
226.8K#271,623View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 16 similar websites and full traffic analytics for Clinical Ink

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Clinical Ink (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Clinical Ink

Premium access

Complete news archive for Clinical Ink

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Clinical Ink

Clinical Ink was founded in 2006.

Clinical Ink is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.

Jonathan Goldman is the CEO of Clinical Ink, as recorded in our data.

Clinical Ink is a funded company, having raised a total of $13.15M across 9 funding rounds to date.

Clinical Ink was founded in 2006 and is headquartered in Winston-Salem, United States. eSource solutions are offered through the SureSource platform, which enables electronic capture of data and documents at clinical trial sites. The CentrosHealth platform supports patient engagement via configurable apps to maintain involvement and compliance. Services target pharmaceutical companies, medical device firms, academic institutions, and contract research organizations in the global clinical trials sector.

Clinical Ink's top competitors include Medidata, Verily and TriNetX.

Clinical Ink offers eCOA, Direct Data Capture, and eConsent.

Clinical Ink has made 1 acquisition, including Digital Artefacts.

Clinical Ink has 9 investors. Key investors include SVB, GI Partners, RTI International, SLR Investment Corp, and Dioko Ventures.

Clinical Ink operates through Clinical Ink.

Yes. Clinical Ink was acquired by GI Partners in August 2020.

Yes. Clinical Ink publishes Clinical ink, with over 1,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available